Horizon Investments, LLC Nektar Therapeutics Transaction History

Horizon Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $139,592 - $269,730	-9,647 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $153,097 - $223,038	9,647 New	9,647 $208,000
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $264,489 - $567,299	-15,641 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $171,089 - $200,339	5,519 Added 54.52%	15,641 $557,000
Q1 2019 May 16, 2019	BUY	$31.58 - $46.35 $127,677 - $187,393	4,043 Added 66.51%	10,122 $340,000

Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $184,983 - $344,375	6,079 New	6,079 $200,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investments, LLC with notifications on news.